semaglutide patent expiry india ▶ opens market, ▶ Generics bring down weight-loss drug prices, ▶ Affordable options expand access in India, ▶ GLP-1 segment set for rapid growth, ▶ India’s weight-loss drug Novo Nordisk patent expiry opens

Wegovy 1.7mg injectable Pen from Novo Nordisk for the treatment of Obesity, those at risk of Diabetes and those with Type 2 Diabetes.

Evidence-based insights to separate fact from fiction for better patient care.

Learn how GLP-1 medications like Semaglutide and Tirzepatide support sustainable metabolic health.

People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and sustainable weight loss, leaving them vulnerable to nutritional deficiencies and muscle loss, say experts at UCL and the University of Cambridge.

This guide explains why each one happens, how to identify which applies to your protocol, and what the research suggests about addressing it.